Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer

Epigenetics

Volumn 8, Issue 7, 2013, Pages 748-755

  Walters, Rhiannon J ^a   Williamson, Elizabeth J ^b,c   English, Dallas R ^b,c   Young, Joanne P ^a   Rosty, Christophe ^a,d,e   Clendenning, Mark ^a   Walsh, Michael D ^a,f   Parry, Susan ^g   Ahnen, Dennis J ^h   Baron, John A ⁱ   Win, Aung Ko ^b   Giles, Graham G ^b,c   Hopper, John L ^b   Jenkins, Mark A ^b   Buchanan, Daniel D ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e Envoi Pathology   (Australia)

^f SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h VA Eastern Colorado Healthcare System   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; DNA methylation; Epigenetics; Peripheral blood; Repetitive sequence

Indexed keywords

FLUOROURACIL; IBUPROFEN; REPETITIVE DNA;

ADULT; ALU SEQUENCE; ARTICLE; BODY MASS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; DNA STRUCTURE; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LONG INTERSPERSED NUCLEOTIDE ELEMENT 1; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MUTATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK; SATELLITE 2;

EID: 84879654168     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.25178     Document Type: Article

References (50)

1. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366:687-96; PMID:22356322; http://dx.doi. org/10.1056/NEJMoa1100370
2. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009; 59:27-41; PMID:19147867; http://dx.doi.org/10.3322/caac.20008
3. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al.; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58:130-60; PMID:18322143; http://dx.doi.org/10.3322/CA.2007.0018
4. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18:1695-8; PMID:19505901; http://dx.doi. org/10.1158/1055-9965.EPI-09-0186
5. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011; 6:828-37; PMID:21636973; http://dx.doi.org/10.4161/epi.6.7.16500
6. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 2008; 9:359-66; PMID:18339581; http://dx.doi.org/10.1016/S1470-2045(08)70038-X
7. Liao LM, Brennan P, van Bemmel DM, Zaridze D, Matveev V, Janout V, et al. LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS One 2011; 6:e27361; PMID:22076155; http://dx.doi. org/10.1371/journal.pone.0027361
8. Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007; 16:108-14; PMID:17220338; http://dx.doi.org/10.1158/1055-9965.EPI-06-0636
9. Choi JY, James SR, Link PA, McCann SE, Hong CC, Davis W, et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009; 30:1889-97; PMID:19584139; http://dx.doi.org/10.1093/carcin/bgp143
10. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005; 33:6823-36; PMID:16326863; http://dx.doi. org/10.1093/nar/gki987
11. Jordan IK, Rogozin IB, Glazko GV, Koonin EV. Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet 2003; 19:68-72; PMID:12547512; http://dx.doi. org/10.1016/S0168-9525(02)00006-9
12. Weiner AM. SINEs and LINEs: the art of biting the hand that feeds you. Curr Opin Cell Biol 2002; 14:343-50; PMID:12067657; http://dx.doi. org/10.1016/S0955-0674(02)00338-1
13. Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet 2009; 10:691-703; PMID:19763152; http://dx.doi. org/10.1038/nrg2640
14. Zhu ZZ, Sparrow D, Hou L, Tarantini L, Bollati V, Litonjua AA, et al. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 2011; 22:437-47; PMID:21188491; http://dx.doi. org/10.1007/s10552-010-9715-2
15. Wu HC, Delgado-Cruzata L, Flom JD, Perrin M, Liao Y, Ferris JS, et al. Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Carcinogenesis 2012; 33:1946-52; PMID:22678115; http://dx.doi. org/10.1093/carcin/bgs201
16. Gao Y, Baccarelli A, Shu XO, Ji BT, Yu K, Tarantini L, et al. Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study. Br J Cancer 2012; 106:585-91; PMID:22173668; http://dx.doi.org/10.1038/bjc.2011.562
17. Pufulete M, Al-Ghnaniem R, Leather AJ, Appleby P, Gout S, Terry C, et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003; 124:1240-8; PMID:12730865; http://dx.doi. org/10.1016/S0016-5085(03)00279-8
18. Lim U, Flood A, Choi SW, Albanes D, Cross AJ, Schatzkin A, et al. Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology 2008; 134:47-55; PMID:18166347; http://dx.doi.org/10.1053/j.gastro. 2007. 10.013
19. Nan H, Giovannucci EL, Wu K, Selhub J, Paul L, Rosner B, et al. Pre-diagnostic leukocyte genomic DNA methylation and the risk of colorectal cancer in women. PLoS One 2013; 8:e59455; PMID:23560049; http://dx.doi.org/10.1371/journal.pone.0059455
20. Kitkumthorn N, Tuangsintanakul T, Rattanatanyong P, Tiwawech D, Mutirangura A. LINE-1 methylation in the peripheral blood mononuclear cells of cancer patients. Clin Chim Acta 2012; 413:869-74; PMID:22326975; http://dx.doi.org/10.1016/j. cca.2012.01.024
21. Brennan K, Flanagan JM. Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 2012; 5:1345-57; PMID:23135621; http://dx.doi.org/10.1158/1940-6207. CAPR-12-0316
22. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K, et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006; 9:199-207; PMID:16530704; http://dx.doi.org/10.1016/j. ccr.2006.02.016
23. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K, et al. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 2004; 68:196-204; PMID:15180700; http://dx.doi. org/10.1046/j.1529-8817.2004.00081.x
24. Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32:e38; PMID:14973332; http://dx.doi.org/10.1093/nar/gnh032
25. Xu X, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, et al. DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J 2012; 26:2657-66; PMID:22371529; http://dx.doi. org/10.1096/fj.11-197251
26. Woo HD, Kim J. Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One 2012; 7:e34615; PMID:22509334; http://dx.doi.org/10.1371/journal. pone.0034615
27. Langevin SM, Koestler DC, Christensen BC, Butler RA, Wiencke JK, Nelson HH, et al. Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenomewide association study. Epigenetics 2012; 7:291-9; PMID:22430805; http://dx.doi.org/10.4161/epi.7.3.19134
28. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395:89-93; PMID:9738504; http://dx.doi.org/10.1038/25779
29. Pornthanakasem W, Kongruttanachok N, Phuangphairoj C, Suyarnsestakorn C, Sanghangthum T, Oonsiri S, et al. LINE-1 methylation status of endogenous DNA double-strand breaks. Nucleic Acids Res 2008; 36:3667-75; PMID:18474527; http://dx.doi. org/10.1093/nar/gkn261
30. Segura-Pacheco B, Perez-Cardenas E, Taja-Chayeb L, Chavez-Blanco A, Revilla-Vazquez A, Benitez-Bribiesca L, et al. Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine. J Transl Med 2006; 4:32; PMID:16893460; http://dx.doi. org/10.1186/1479-5876-4-32
31. Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, et al. DNA hypermethylation as a chemotherapy target. Cell Signal 2011; 23:1082-93; PMID:21345368; http://dx.doi.org/10.1016/j.cellsig.2011.02.003
32. Candelaria M, de la Cruz-Hernandez E, Taja-Chayeb L, Perez-Cardenas E, Trejo-Becerril C, Gonzalez-Fierro A, et al. DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells. PLoS One 2012; 7:e29181; PMID:22427797; http://dx.doi.org/10.1371/journal.pone.0029181
33. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000; 9:849-53; PMID:10952104
34. Zhang Y, Chen H. Genistein, an epigenome modifier during cancer prevention. Epigenetics 2011; 6:888-91; PMID:21610327; http://dx.doi.org/10.4161/epi.6.7.16315
35. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, et al. DNA hypermethylation of promoter of gene p53 and p16 in arsenicexposed people with and without malignancy. Toxicol Sci 2006; 89:431-7; PMID:16251483; http://dx.doi. org/10.1093/toxsci/kfj030
36. Zhang FF, Cardarelli R, Carroll J, Zhang S, Fulda KG, Gonzalez K, et al. Physical activity and global genomic DNA methylation in a cancer-free population. Epigenetics 2011; 6:293-9; PMID:21178401; http://dx.doi.org/10.4161/epi.6.3.14378
37. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7:e41361; PMID:22848472; http://dx.doi. org/10.1371/journal.pone.0041361
38. Toft P, Svendsen P, Tønnesen E, Rasmussen JW, Christensen NJ. Redistribution of lymphocytes after major surgical stress. Acta Anaesthesiol Scand 1993; 37:245-9; PMID:8517098; http://dx.doi. org/10.1111/j.1399-6576.1993.tb03708.x
39. Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, et al.; Colon Cancer Family Registry. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:2331-43; PMID:17982118; http://dx.doi.org/10.1158/1055-9965. EPI-07-0648
40. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20:1043-8; PMID:11844828; http://dx.doi. org/10.1200/JCO.20.4.1043
41. Cicek MS, Lindor NM, Gallinger S, Bapat B, Hopper JL, Jenkins MA, et al. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population-and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn 2011; 13:271-81; PMID:21497289; http://dx.doi.org/10.1016/j.jmoldx.2010.12.004
42. Walsh MD, Cummings MC, Buchanan DD, Dambacher WM, Arnold S, McKeone D, et al. Molecular, pathologic, and clinical features of earlyonset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin Cancer Res 2008; 14:1692-700; PMID:18310315; http://dx.doi. org/10.1158/1078-0432.CCR-07-1849
43. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28:E32; PMID:10734209; http://dx.doi. org/10.1093/nar/28.8.e32
44. Poynter JN, Siegmund KD, Weisenberger DJ, Long TI, Thibodeau SN, Lindor N, et al.; Colon Cancer Family Registry Investigators. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 2008; 17:3208-15; PMID:18990764; http://dx.doi.org/10.1158/1055-9965.EPI-08-0512
45. Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, et al. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One 2010; 5:e11636; PMID:20661287; http://dx.doi. org/10.1371/journal.pone.0011636
46. Clendenning M, Hampel H, LaJeunesse J, Lindblom A, Lockman J, Nilbert M, et al. Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat 2006; 27:490-5; PMID:16619239; http://dx.doi.org/10.1002/humu.20318
47. Walsh MD, Buchanan DD, Cummings MC, Pearson SA, Arnold ST, Clendenning M, et al. Lynch syndromeassociated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res 2010; 16:2214-24; PMID:20215533; http://dx.doi.org/10.1158/1078-0432.CCR-09-3058
48. Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008; 135:419-28; PMID:18602922; http://dx.doi.org/10.1053/j.gastro.2008.04.026
49. Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, et al. Germline MutY human homologue mutations and colorectal cancer: a multisite casecontrol study. Gastroenterology 2009; 136:1251-60; PMID:19245865; http://dx.doi.org/10.1053/j.gastro. 2008. 12.050
50. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215; PMID:3344216; http://dx.doi.org/10.1093/nar/16.3.1215